Achillion Pharma CVR
13F holders, Q1 2024 (March 31)2holders
$0.04avg. 13F price*
At the end of Q1 2024, 2 institutions reported holding Achillion Pharma CVR in their 13F filings. The largest holders were Pacer Advisors, Inc. ($3K) and Rhumbline Advisers ($0).
- Company
- Achillion Pharma CVR
- CUSIP
- 004CVR031
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 2 holders
| Pacer Advisors, Inc. | 0.00% | No change | 6,273 | $3K |
| Rhumbline Advisers | 0.00% | No change | 53,312 | $0 |
"% of holder's portfolio" is ACHILLION PHARMA CVR's weight in each manager's 13F, not the share of Achillion Pharma CVR the manager owns.